A ONE YEAR STUDY ON THE USE OF TRANEXAMIC ACID IN BENIGN PROSTATIC HYPERPLASIA SURGERY
- Conditions
- BENIGN PROSTATIC HYPERTROPHYTherapeutic area: Diseases [C] - Male diseases of the urinary and reproductive systems [C12]
- Registration Number
- EUCTR2013-004320-11-ES
- Lead Sponsor
- CARLOS SANTOS VILLAR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
MALE OVER 50 YEARS PERFORMING TRANSURETHRAL RESECTION OF PROSTATE OR RETROPUBIC ADENOMECTOMY BECAUSE OF BENIGN PROSTATIC HYPERTROPHY
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 50
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 48
Exclusion Criteria
PATIENT REFUSAL TO THEIR PARTICIPATION IN THE STUDY. EMEPERGENCY SURGERY. PAST OF ARTERIAL OR VENOUS THROMBOSIS. THROMBOFILIA. KIDNEY INJURY. PAST OF CONVULSION
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: COMPARING PERIOPERATIVE ANEMIA;Secondary Objective: NEED FOR TRANSFUSION<br>COMPLICATIONS<br>LENGTH OF HOSPITAL STAY;Primary end point(s): HEMOGLOBIN, HEMATOCRIT, PLATELETS, COAGULATIONS TIMES, FIBRINOGEN;Timepoint(s) of evaluation of this end point: FIRST DAY AND FIFTH DAY
- Secondary Outcome Measures
Name Time Method Secondary end point(s): NEED FOR TRANSFUSION<br>COMPLICATIONS<br>LENGTH OF HOSPITAL STAY;Timepoint(s) of evaluation of this end point: FIRST DAY AND FIFTH DAY